IRadimed Corporation (IRMD)
Stock Price:
$21.75 USD
-0.16 (-0.73%)
Updated Aug 10, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
262.09M |
| Revenue (ttm) |
36.33M |
| Net Income (ttm) |
5.35M |
| Shares Out |
12.24M |
| EPS (ttm) |
0.44 |
| PE Ratio |
49.43 |
| Forward PE |
60.98 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 10, 2020 |
| Last Price |
$21.75 |
| Previous Close |
$21.91 |
| Change ($) |
-0.16 |
| Change (%) |
-0.73% |
| Day's Open |
21.79 |
| Day's Range |
21.21 - 22.27 |
| Day's Volume |
54,272 |
| 52-Week Range |
14.42 - 28.43 |
More Stats
| Market Cap |
262.09M |
| Enterprise Value |
217.14M |
| Earnings Date (est) |
Oct 28, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
12.24M |
| Float |
5.53M |
| EPS (basic) |
0.48 |
| EPS (diluted) |
0.44 |
| FCF / Share |
0.69 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
2.02% |
| FCF Yield |
3.17% |
| Payout Ratio |
n/a |
| Shares Short |
435,054 |
| Short Ratio |
6.36 |
| Short % of Float |
6.70% |
| Beta |
1.31 |
| PE Ratio |
49.43 |
| Forward PE |
60.98 |
| P/FCF Ratio |
31.51 |
| PS Ratio |
7.21 |
| PB Ratio |
4.60 |
| Revenue |
36.33M |
| Operating Income |
2.57M |
| Net Income |
5.35M |
| Free Cash Flow |
8.32M |
| Net Cash |
44.95M |
| Net Cash / Share |
3.73 |
| Gross Margin |
81.76% |
| Operating Margin |
7.06% |
| Profit Margin |
14.70% |
| FCF Margin |
22.90% |
| ROA |
5.74% |
| ROE |
10.15% |
| ROIC |
14.40% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$28.00*
(28.74% upside)
Low
26.0
Current: $21.75
High
30.0
Target: 28.00
*Average 12-month price target from 2 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|
| Revenue | 38.52 | 30.44 | 23.08 | 32.50 | 31.59 | 15.65 | 11.34 | 7.69 |
| Revenue Growth | 26.54% | 31.88% | -28.97% | 2.86% | 101.84% | 38.03% | 47.56% | - |
| Gross Profit | 29.70 | 23.23 | 17.51 | 26.34 | 25.75 | 12.25 | 8.49 | 5.56 |
| Operating Income | 8.65 | 6.00 | 1.29 | 10.92 | 11.51 | 3.07 | 2.79 | 1.42 |
| Net Income | 9.63 | 6.30 | 0.50 | 7.21 | 7.53 | 2.05 | 1.94 | 0.97 |
| Shares Outstanding | 11.28 | 10.76 | 10.64 | 10.72 | 11.00 | 8.74 | 7.00 | 7.00 |
| Earnings Per Share | 0.78 | 0.52 | 0.04 | 0.61 | 0.60 | 0.20 | 0.22 | 0.11 |
| EPS Growth | 50% | 1200% | -93.44% | 1.67% | 200% | -9.09% | 100% | - |
| Operating Cash Flow | 10.23 | 7.38 | 3.42 | 9.41 | 7.65 | 2.59 | 1.47 | 1.51 |
| Capital Expenditures | -0.49 | -0.26 | -0.82 | -1.52 | -0.31 | -0.61 | -0.19 | -0.16 |
| Free Cash Flow | 9.75 | 7.11 | 2.59 | 7.88 | 7.33 | 1.98 | 1.28 | 1.35 |
| Cash & Equivalents | 46.25 | 34.38 | 26.34 | 25.68 | 26.97 | 17.37 | 2.71 | 1.95 |
| Total Debt | 2.96 | - | - | - | - | - | 0.01 | 0.52 |
| Net Cash / Debt | 43.29 | 34.38 | 26.34 | 25.68 | 26.97 | 17.37 | 2.70 | 1.43 |
| Assets | 66.73 | 48.44 | 39.01 | 37.19 | 35.24 | 23.31 | 6.99 | 5.55 |
| Liabilities | 11.20 | 6.50 | 6.08 | 5.31 | 3.31 | 2.42 | 1.56 | 2.33 |
| Book Value | 55.52 | 41.95 | 32.93 | 31.89 | 31.93 | 20.89 | 5.42 | 3.22 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
IRadimed Corporation |
| Country |
United States |
| Employees |
114 |
| CEO |
Roger Susi |
Stock Information
| Ticker Symbol |
IRMD |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: IRMD |
| IPO Date |
July 16, 2014 |
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.